WeightWatchers CEO Sima Sistani talks TikTok, Telehealth Deal on GLP-1/Ozempic and Why She Took the Job

WeightWatchers CEO Sima Sistani talks TikTok,...

Up next

Life After Trump: Astead Herndon On What’s Next for American Politics

Political journalist Astead Herndon is using his new Vox podcast America, Actually with Astead Herndon to ask what feels like an unfathomable question: What does our country look like after President Trump; and can we even talk about politics without putting him at the center? As ...  Show more

The WNBA Is On a Winning Streak. Is It Sustainable?

Kara sits down with New York Liberty owner Clara Wu Tsai to talk about betting big on the WNBA and why the momentum for women’s sports isn’t slowing down. Clara explains why she saw the Liberty as a distressed asset worth rebuilding and how investments in players, facilities and ...  Show more

Recommended Episodes

The Big Business Behind Weight Loss Drugs
Chasing Life

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Show more

WeightWatchers CEO Explains Why ‘We Got It Wrong’
Chasing Life

Long before WeightWatchers became a weight loss empire, the legacy dieting company started as a small support group in the 1960s. The company rose to popularity preaching a message of moderation and making healthy choices. But in what some call a surprising pivot, WeightWatchers ...  Show more

Is Ozempic Really A Weight Loss Wonder Drug?
The Quicky

You may have heard about a new miracle weight loss drug called Ozempic. Videos have been spreading online of users claiming insane weight loss in short periods of time. Even celebrities like Kim Kardashian have been accused of using it to slim down. There's just one problem...Oze ...  Show more

Those New Obesity Drugs Really Work–If You Can Afford Them
Big Take

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ...  Show more